Pacific Biosciences Of California | PACB - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Agilent USD 475M 10M 2026-06
Bruker USD 226.5M 12.4M 2026-09
Danaher USD 2.16B 87M 2026-09
General Electric Aerospace USD 1.09B 40M 2026-09
Illumina USD 281M 8M 2026-09
Myriad Genetics USD 122.3M 6.7M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quidel USD 182.7M 7M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
Standard Biotools USD 16.39M 2.22M 2026-06
Thermo Fisher Scientific USD 1.86B 46M 2026-09
Waters USD 398M 7M 2026-09